UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 42

Sortiert nach

A phase I dose escalation study of BIBW 2992, an irreversible dual inhibitor of epidermal growth factor receptor 1 (EGFR) and 2 (HER2) tyrosine kinase in a 2-week on, 2-week off schedule in patients with advanced solid tumours

British journal of cancer, 2008-01, Vol.98 (1), p.80-85

2008

Volltextzugriff (PDF)

2537 Preliminary findings from PLATO: A two-period, phase 4, randomized, double-blind, placebo-controlled study of continued enzalutamide treatment beyond progression in men with chemotherapy-naïve metastatic castration-resistant prostate cancer (mCRPC)

European journal of cancer (1990), 2015-09, Vol.51, p.S487-S487

2015

Volltextzugriff (PDF)

2501 ORAL A randomized, open-label, phase 2 study of enzalutamide as neoadjuvant therapy for patients undergoing prostatectomy for localized prostate cancer

European journal of cancer (1990), 2015-09, Vol.51, p.S473-S473

2015

Volltextzugriff (PDF)

Stromal antigen targeting by a humanised monoclonal antibody: an early phase II trial of sibrotuzumab in patients with metastatic colorectal cancer

Onkologie, 2003, Vol.26 (1), p.44-48

2003

Volltextzugriff (PDF)

Phase I and pharmacokinetic study of BIBX 1382 BS, an epidermal growth factor receptor (EGFR) inhibitor, given in a continuous daily oral administration

European journal of cancer (1990), 2002-05, Vol.38 (8), p.1072-1080

2002

Volltextzugriff (PDF)

Population pharmacokinetics of sibrotuzumab, a novel therapeutic monoclonal antibody, in cancer patients

Investigational new drugs, 2004-01, Vol.22 (1), p.39-52

2004

Volltextzugriff (PDF)

A Phase I Dose-Escalation Study of Sibrotuzumab in Patients with Advanced or Metastatic Fibroblast Activation Protein-positive Cancer

Clinical cancer research, 2003-05, Vol.9 (5), p.1639-1647

2003

Volltextzugriff (PDF)

Evidence for an anion exchange mechanism for uptake of conjugated bile acid from the rat jejunum

American journal of physiology: Gastrointestinal and liver physiology, 1999-03, Vol.276 (3), p.G737-G742

1999

Volltextzugriff (PDF)

Carrier-mediated jejunal absorption of conjugated bile acids in the guinea pig

Gastroenterology (New York, N.Y. 1943), 1996-04, Vol.110 (4), p.1098-1106

1996

Volltextzugriff (PDF)

Cyclic Adenosine-3′,5′-Monophosphate Production Is Greater in Rabbit Duodenal Crypt Than in Villus Cells

Scandinavian journal of gastroenterology, 1996, Vol.31 (3), p.233-239

1996

Volltextzugriff (PDF)

Intestinal absorption of sodium dodecyl sulfate in the rodent: evidence for paracellular absorption

American journal of physiology: Gastrointestinal and liver physiology, 1997-03, Vol.272 (3 Pt 1), p.G498-G506

1997

Volltextzugriff (PDF)

A phase I dose escalation study of BIBW 2992, an irreversible dual EGFR/HER2 receptor tyrosine kinase inhibitor, in a continuous schedule in patients with advanced solid tumours

Journal of clinical oncology, 2006-06, Vol.24 (18_suppl), p.2074-2074

2006

Volltextzugriff (PDF)

A phase I dose escalation study of BIBW 2992, an irreversible dual EGFR/HER2 receptor tyrosine kinase inhibitor, in a 3 week on 1 week off schedule in patients with advanced solid tumors

Journal of clinical oncology, 2006-06, Vol.24 (18_suppl), p.3091-3091

2006

Volltextzugriff (PDF)

A phase I dose escalation study off BIBW 2992, an irreversible dual inhibitor of epidermal growth factor receptor I (EGFR) and 2 (HER2) tyrosine kinase in a 2-week on, 2-week off schedule in patients with advanced solid tumours

British journal of cancer, 2008, Vol.98 (1), p.80-85

2008

Volltextzugriff (PDF)

Phase 1 study with BIBW 2992, an irreversible dual tyrosine kinase inhibitor of epidermal growth factor receptor 1 (EGFR) and 2 (HER2) in a 2 week on 2 week off schedule

Journal of clinical oncology, 2006-06, Vol.24 (18_suppl), p.3025-3025

2006

Volltextzugriff (PDF)

A phase I dose escalation study of BIBW 2992, an irreversible dual EGFR/HER2 receptor tyrosine kinase inhibitor, in patients with advanced solid tumours

Journal of clinical oncology, 2006-06, Vol.24 (18_suppl), p.3027-3027

2006

Volltextzugriff (PDF)

Influence of heparin treatment on biochemical markers of an activation of the coagulation system

Thrombosis research, 1992-05, Vol.66 (2), p.121-131

1992

Volltextzugriff (PDF)

567 POSTER Efficacy of BIBW 2992, an irreversible dual EGFR/HER2 receptor tyrosine kinase inhibitor, in combination with cytotoxic agents

European journal of cancer supplements, 2006-11, Vol.4 (12), p.172-172

2006

Volltextzugriff (PDF)

Extracorporeal shock wave lithotripsy of gallstones in different biles and water in vitro

Digestion, 1994, Vol.55 (3), p.175

1994

Volltextzugriff (PDF)

573 POSTER Phase I study of BIBW2992, an oral irreversible dual EGFR/HER2 inhibitor, showing activity in tumors with mutated EGFR

European journal of cancer supplements, 2006-11, Vol.4 (12), p.173-174

2006

Volltextzugriff (PDF)

Acid/Base Transporters in Human Duodenal Enterocytes

Scandinavian journal of gastroenterology, 1998, Vol.33 (10), p.1039-1046

1998

Volltextzugriff (PDF)

Evidence for an anion exchange mechanism for uptake of conjugated bile acid from the rat jejunum

American journal of physiology: Gastrointestinal and liver physiology, 1999-03, Vol.39 (3), p.G737-G742

1999

Volltextzugriff (PDF)

Bile acid metabolism and biliary secretion in patients receiving orthotopic liver transplants: Differing effects of cyclosporine and FK 506

Hepatology (Baltimore, Md.), 1994-06, Vol.19 (6), p.1381-1389

1994

Volltextzugriff (PDF)

Intestinal absorption of sodium dodecyl sulfate in the rodent : evidence for paracellular absorption

American journal of physiology: Gastrointestinal and liver physiology, 1997-03, Vol.35 (3), p.G498-G506

1997

Volltextzugriff (PDF)

Successful topical dissolution of cholesterol gallbladder stones using ethyl propionate

Digestive diseases and sciences, 1997-06, Vol.42 (6), p.1274-1282

1997

Volltextzugriff (PDF)

1 – 25 von 42

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(40)
Mit Volltextzugriff
(36)

Publikationsform

Artikel
(42)

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(19)
Life Sciences & Biomedicine
(18)
Humans
(16)
Biological And Medical Sciences
(12)
Male
(12)
Female
(10)
Middle Aged
(10)
Gastroenterology & Hepatology
(9)
Aged
(8)
Adult
(7)
Animals
(7)
Dose-Response Relationship, Drug
(6)
Fundamental And Applied Biological Sciences. Psychology
(6)
Medical Sciences
(6)
Vertebrates: Digestive System
(5)
Cholelithiasis - Therapy
(4)
Immunotherapy
(4)
Intestine. Mesentery
(4)
Oncology
(4)
Pharmacokinetics
(4)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

A phase I dose escalation study of BIBW 2992, an irreversible dual inhibitor of epidermal growth factor receptor 1 (EGFR) and 2 (HER2) tyrosine kinase in a 2-week on, 2-week off schedule in patients with advanced solid tumours

2537 Preliminary findings from PLATO: A two-period, phase 4, randomized, double-blind, placebo-controlled study of continued enzalutamide treatment beyond progression in men with chemotherapy-naïve metastatic castration-resistant prostate cancer (mCRPC)

2501 ORAL A randomized, open-label, phase 2 study of enzalutamide as neoadjuvant therapy for patients undergoing prostatectomy for localized prostate cancer

Stromal antigen targeting by a humanised monoclonal antibody: an early phase II trial of sibrotuzumab in patients with metastatic colorectal cancer

Phase I and pharmacokinetic study of BIBX 1382 BS, an epidermal growth factor receptor (EGFR) inhibitor, given in a continuous daily oral administration

Population pharmacokinetics of sibrotuzumab, a novel therapeutic monoclonal antibody, in cancer patients

A Phase I Dose-Escalation Study of Sibrotuzumab in Patients with Advanced or Metastatic Fibroblast Activation Protein-positive Cancer

Evidence for an anion exchange mechanism for uptake of conjugated bile acid from the rat jejunum

Carrier-mediated jejunal absorption of conjugated bile acids in the guinea pig

Cyclic Adenosine-3′,5′-Monophosphate Production Is Greater in Rabbit Duodenal Crypt Than in Villus Cells

Intestinal absorption of sodium dodecyl sulfate in the rodent: evidence for paracellular absorption

A phase I dose escalation study of BIBW 2992, an irreversible dual EGFR/HER2 receptor tyrosine kinase inhibitor, in a continuous schedule in patients with advanced solid tumours

A phase I dose escalation study of BIBW 2992, an irreversible dual EGFR/HER2 receptor tyrosine kinase inhibitor, in a 3 week on 1 week off schedule in patients with advanced solid tumors

A phase I dose escalation study off BIBW 2992, an irreversible dual inhibitor of epidermal growth factor receptor I (EGFR) and 2 (HER2) tyrosine kinase in a 2-week on, 2-week off schedule in patients with advanced solid tumours

Phase 1 study with BIBW 2992, an irreversible dual tyrosine kinase inhibitor of epidermal growth factor receptor 1 (EGFR) and 2 (HER2) in a 2 week on 2 week off schedule

A phase I dose escalation study of BIBW 2992, an irreversible dual EGFR/HER2 receptor tyrosine kinase inhibitor, in patients with advanced solid tumours

Influence of heparin treatment on biochemical markers of an activation of the coagulation system

567 POSTER Efficacy of BIBW 2992, an irreversible dual EGFR/HER2 receptor tyrosine kinase inhibitor, in combination with cytotoxic agents

Extracorporeal shock wave lithotripsy of gallstones in different biles and water in vitro

573 POSTER Phase I study of BIBW2992, an oral irreversible dual EGFR/HER2 inhibitor, showing activity in tumors with mutated EGFR

Acid/Base Transporters in Human Duodenal Enterocytes

Evidence for an anion exchange mechanism for uptake of conjugated bile acid from the rat jejunum

Bile acid metabolism and biliary secretion in patients receiving orthotopic liver transplants: Differing effects of cyclosporine and FK 506

Intestinal absorption of sodium dodecyl sulfate in the rodent : evidence for paracellular absorption

Successful topical dissolution of cholesterol gallbladder stones using ethyl propionate

Suchergebnisse filtern